Stueland Katherine: insider trades.
Stueland Katherine reported 8 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($1.3M), across 1 company.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 6
- Companies
- 1
- Name as filed
- Stueland Katherine
Companies
| Company | Relationship | Transactions |
|---|---|---|
| GeneDx Holdings Corp. (WGS) | Director, Officer · CHIEF EXECUTIVE OFFICER | 8 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | GeneDx Holdings Corp. | S | 4,141 | $98.27 | 118,515 | Form 4 |
| 2026-09-16 | GeneDx Holdings Corp. | S | 1,525 | $96.9 | 122,656 | Form 4 |
| 2026-09-16 | GeneDx Holdings Corp. | S | 148 | $95.41 | 124,181 | Form 4 |
| 2026-09-16 | GeneDx Holdings Corp. | S | 1,648 | $94.26 | 124,329 | Form 4 |
| 2026-09-16 | GeneDx Holdings Corp. | M | 18,750 | $0 | 125,977 | Form 4 |
| 2026-09-16 | GeneDx Holdings Corp. | S | 3,039 | $99 | 115,476 | Form 4 |
| 2026-09-09 | GeneDx Holdings Corp. | M | 6,547 | $0 | 110,919 | Form 4 |
| 2026-09-09 | GeneDx Holdings Corp. | S | 3,692 | $84.22 | 107,227 | Form 4 |
Questions
What stock did Stueland Katherine buy or sell?
Stueland Katherine reported 8 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 6 sales ($1.3M), across 1 company.
Is Stueland Katherine the same person as other filers with this name?
This page covers SEC CIK 1689575 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/stueland-katherine-1689575.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.